J&J News - Facebook
J&J News. 55,466 likes · 4,460 talking about this. J&J News brings you all the facts.
J&J sues government over 340B proposal; AHA says J&J's legal …
19 hours ago · Johnson and Johnson Nov. 12 filed a lawsuit against the Department of Health and Human Services and the Health Resources and Services Administration asking a federal court …
J&J to acquire Ambrx Biopharma, a cancer drug developer, for $2B
Jan 8, 2024 · J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion. Johnson & Johnson said it will acquire Ambrx Biopharma for $2 billion, picking up a drugmaker …
J&J plans to split into two companies, separating consumer ... - CNBC
Nov 12, 2021 · Health-care conglomerate Johnson & Johnson announced plans Friday to split its consumer products business from its pharmaceutical and medical device operations, creating …
Johnson & Johnson (JNJ) Latest Stock News & Headlines
Get the latest Johnson & Johnson (JNJ) stock news and headlines to help you in your trading and investing decisions.
J&J beats Wall St estimates on strong drug sales ahead of Stelara ...
July 17 (Reuters) - Johnson & Johnson (JNJ.N) beat estimates for second-quarter profit and revenue on Wednesday, driven by strong sales of its drugs, including cancer treatment …
Johnson & Johnson to pay $6.5 billion to resolve nearly all ... - NBC News
May 1, 2024 · Johnson & Johnson on Wednesday said it plans to pay $6.5 billion over 25 years to settle nearly all of the thousands of lawsuits in the U.S. claiming its talc-based products …
Latest news - Johnson & Johnson
A collection of stories that highlight the way Johnson & Johnson is making an impact in the lives of its consumers, and the latest press releases from the company.
Johnson & Johnson Announces Real-World Evidence and Phase 3 …
Sep 21, 2021 · Innovative Medicine. Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 …
Johnson & Johnson Posts Higher Quarterly Sales, Raises 2023 …
Apr 19, 2023 · Johnson & Johnson JNJ 0.32% raised its full-year sales and earnings outlook after revenue rose 5.6% in the first quarter, lifted by demand for everything from Tylenol to the …